Associate Territory Manager - UPPER EAST MANHATTAN NY CMH2_170867

Chester, Maryland, United States

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should have a strong understanding of the healthcare market and payer landscape, along with the ability to utilize business insight tools, data, and analytics. Experience with AI company-approved tools and other analytical capabilities is required, as well as demonstrated learning agility to understand disease states, clinical trials, and product labels. The role requires a growth mindset and the ability to build and maintain relationships with internal stakeholders.

Responsibilities

The Associate Territory Manager will be responsible for account-based selling to healthcare providers who prescribe and influence treatment for Lilly's portfolio, including multiple HCP specialties and key hospital accounts. They will promote the full portfolio of priority products, tailor territory strategies to grow business outcomes, and navigate the healthcare environment to impact key stakeholders. Responsibilities include planning and engaging in patient-centered dialogues, driving consistent ways of working, achieving targeted sales and execution metrics, owning customer relationships for product promotion and market access, and holding self-accountability for results across all accounts.

Skills

Account-based selling

Healthcare provider engagement

Brand promotion

Relationship building

Sales execution

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free